Stocks · Health care · Pharmaceutical Preparations

Stoke Therapeutics, Inc.

STOK Clue Score65
United States Fiscal year ends December CIK 0001623526 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Barry Ticho
19 Mar 2026
Chief Medical Officer
Sold after exercise
1,461
$29.99
$43.82K
Arthur Tzianabos
10 Mar 2026
Interim Executive Chair
Sold after exercise
4,355
$40.00
$174.21K

What was left out

Form 4 filings counted 54
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 46
Sales straight out of an exercise 2
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 261,194
History held since 20 Jun 2019